Budapest, Hungary

Ildikó Horváth

This inventor holds 1 USPTO granted patent. Top assignee: Ivax Drug Research Institute. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ildikó Horváth. Retrieved from https://idiyas.com/inventor/ildikó-horváth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ildikó Horváth: Pioneer in Microbial Hydroxylation

Introduction: Ildikó Horváth is an innovative inventor based in Budapest, Hungary. He has made significant contributions to the field of biotechnology, particularly through his patented microbial process for the preparation of valuable pharmaceutical compounds.

Latest Patents: Ildikó holds a patent titled "Hydroxylation of compactin pravastatin by micromonospora." This invention describes a novel method for producing a compound of formula (I) from a compound of general formula (II). The process involves the submerged culture of a specific strain capable of 6β-hydroxylating the compound, using aerobic fermentation. The invention highlights the cultivation techniques, conditions, and purification methods necessary for the successful bioconversion of the substrate.

Career Highlights: Ildikó is affiliated with the Ivax Drug Research Institute, where he has honed his skills in drug research and development. His expertise in microbial biotechnology has positioned him as a key figure in the pharmaceutical industry, driving forward innovative solutions for drug production.

Collaborations: Throughout his career, Ildikó has collaborated with talented individuals such as Antónia Jekkel and Gábor Ambrus. These partnerships have enabled him to enhance his research capabilities and contribute effectively to the advancements in drug development.

Conclusion: Ildikó Horváth’s work not only showcases his dedication to advancing biotechnology but also illustrates the importance of collaborative efforts in innovation. His patented method for the hydroxylation of compactin pravastatin marks a significant step forward in pharmaceutical manufacturing, demonstrating the potential of microbial processes in creating essential therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…